6GGN:
reference: In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor., Vaupel A, Holzer P, Ferretti S, Guagnano V, Kallen J, Mah R, Masuya K, Ruetz S, Rynn C, Schlapbach A, Stachyra T, Stutz S, Todorov M, Jeay S, Furet P, Bioorg Med Chem Lett. 2018 Aug 26. pii: S0960-894X(18)30703-0. doi:, 10.1016/j.bmcl.2018.08.027. PMID: 30217415

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).